Cleared Traditional

Olea Sphere V3.0 (K152602) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K152602 · Olea Medical · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2016
Decision
174d
Days
Class 2
Risk

K152602 is an FDA 510(k) clearance for the Olea Sphere V3.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Olea Medical (La Ciotat, FR). The FDA issued a Cleared decision on March 3, 2016 after a review of 174 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Olea Medical devices

Submission Details

510(k) Number K152602 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 11, 2015
Decision Date March 03, 2016
Days to Decision 174 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
67d slower than avg
Panel avg: 107d · This submission: 174d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 788
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K152602.
Xeleris 4.0 Processing and Review Workstation
K153355 · Ge Healthcare · Mar 2016
syngo Application Software VD11
K153346 · Siemens Medical Solutions USA, Inc. · Mar 2016
syngo.via MI Workflows
K160426 · Siemens Medical Solutions USA, Inc. · Mar 2016
syngo.via MI Workflows
K160317 · Siemens Medical Solutions USA, Inc. · Feb 2016
syngo.MR Neurology, syngo.MR Oncology
K151353 · Siemens Medical Solutions USA, Inc. · Aug 2015
syngo.via MI Workflows
K151192 · Siemens Medical Solutions USA, Inc. · Jun 2015